Partnership sees cervical vaccines for poorer countries

A major campaigner in vaccines for poorer countries announced plans on Thursday for innoculating up to two million women and girls against cervical cancer by 2015.

GAVI, a Geneva-based public-private partnership set up in 2000, said the initiative was approved at a board meeting in the Bangladesh capital of Dhaka.

The scheme depends on price negotiations with manufacturers and assurances from governments that they can distribute the vaccines effectively, it said in a press release.

Nine countries are candidates for the vaccine, although their names are being withheld at this stage, said a spokesman for GAVI, reached by phone from Paris.

The cost of the project cannot be disclosed immediately because of the sensitive nature of the price talks, he added.

The vaccine shields against the (HPV), which causes some 275,000 deaths each year from , 88 percent of them in developing countries.

HPV vaccines have been available in rich countries since 2007. It can take 10 or 15 years for advanced vaccines to be rolled out in poorer settings.

"The is critical to women and girls in poorer countries because they usually do not have access to screening to prevent cervical cancer and treatment taken for granted in richer nations," said GAVI's chief executive, Seth Berkley.

The GAVI board also agreed to seek funds for vaccines against German measles, also called rubella, a childhood disease which is highly dangerous for , leading to miscarriage, stillbirth and .

add to favorites email to friend print save as pdf

Related Stories

WHO approves cervical cancer vaccine Cervarix

Jul 09, 2009

(AP) -- The World Health Organization has approved a second cervical cancer vaccine, this one made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries ...

Vaccine against world's top child killer launched

Feb 14, 2011

A vaccine against pneumonia, the leading cause of child deaths around the world, was rolled out in Kenya Monday and is expected to save hundreds of thousands of lives in coming years.

Recommended for you

Genetics of cancer: Non-coding DNA can finally be decoded

54 minutes ago

Cancer is a disease of the genome resulting from a combination of genetic modifications (or mutations). We inherit from our parents strong or weak predispositions to developing certain kinds of cancer; in addition, we also ...

New view of stomach cancer could hasten better therapies

54 minutes ago

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations ...

Statin use decreases the risk of Barrett's esophagus

3 hours ago

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the Americ ...

User comments